Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $51.22 M | -80.99% |
2023 | $0.26 B | 0.63% |
2022 | $0.26 B | 97.85% |
2021 | $0.13 B | -41.09% |
2020 | $0.22 B | 93.47% |
2019 | $0.11 B | -83.14% |
2018 | $0.70 B | 537.75% |
2017 | $0.11 B | -73.45% |
2016 | $0.41 B | -10.96% |
2015 | $0.46 B | -44.68% |
2014 | $0.84 B | 249.24% |
2013 | $0.24 B |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.13 B | $0.59 B | ๐บ๐ธ USA |
Pfizer PFE | $10.32 M | $0.31 B | ๐บ๐ธ USA |
AbbVie ABBV | $8.72 M | $79.91 M | ๐บ๐ธ USA |
Eli Lilly LLY | $56.64 M | $0.12 B | ๐บ๐ธ USA |
Amgen AMGN | $52.25 M | $0.21 B | ๐บ๐ธ USA |
Biogen BIIB | $22.53 M | $74.47 M | ๐บ๐ธ USA |
Illumina ILMN | $0.94 M | $95.59 M | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $1.39 M | $59.49 M | ๐บ๐ธ USA |
Merck MRK | $6.57 M | $0.15 B | ๐บ๐ธ USA |